Novavax hasn’t yet submitted a complete EUA application. They finalized the data by submitting the outstanding manufacturing component but the FDA requires 30 days to review the data before it will accept the EUA application, so this won’t be done until the end of the month. Then it will take weeks to review before approving, if it bothers.
“ it will take weeks to review before approving, if it bothers.”
The emergency could reasonably be considered to be over next month. Also, another vaccine and treatments have been approved and are available. They certainly could find reasonable grounds to skip it.
Since it was one of the Operation Warp Speed candidates however, there may be a special commitment to consider it. I believe the Government committed to buying 100 million doses, like it did for the others (not that this Administration would be shy about building another bonfire of taxpayer money, if it suited their ideology, or corrupt purposes).
People will still be dying in the USA, so they may fear political blowback from denying approval. Also, the global market is still short of supply, and other areas (like Asia) have yet to have their Omicron waves.